Skyrocketing insurance premiums are a growing problem - and not only for homeowners, new report details Skyrocketing insurance premiums aren't just a major problem for homeowners from California to ...
Shares of Lumos Pharma were set to rise after investment firm Double Point Ventures agreed to buy the biopharmaceutical company for $38 million in cash plus potential milestone payments.
The stock (WGO) sank 8% toward a three month low, which put it on track for the biggest one-day since October 2022. For the quarter to Aug. 31, the company swung to a net loss of $29.1 million, or ...